The Joint (The Joint) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is The Joint Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Joint is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of The Joint's Risk Assessment

For the Medical Care Facilities subindustry, The Joint's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Joint's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Joint's Risk Assessment falls into.

The Joint (NAS:JYNT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

The Joint Risk Assessment Related Terms

Thank you for viewing the detailed overview of The Joint's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

The Joint (The Joint) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Joint Corp (NAS:JYNT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260

Website

https://www.thejoint.com

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sale of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

Executives

Bandera Partners Llc	10 percent owner	50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Peter D Holt	officer: Chief Operating Officer	16767 N. PERIMETER DR., SUITE 240, SCOTTSDALE AZ 85260
Jake Singleton	officer: Chief Financial Officer	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Ronald V Davella	director	2600 E SOUTHLAKE BLVD., STE 120-359, SOUTHLAKE TX 76092
Glenn J Krevlin	10 percent owner	600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Matthew E Rubel	director	3231 SE SIXTH AVENUE, TOPEKA KS 66607
Gregory Bylinsky	10 percent owner	C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Jefferson Gramm	10 percent owner	C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Amos James H. Jr	director	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
John P Meloun	officer: Chief Financial Officer	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
Abe Hong	director	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Glenhill Advisors Llc	10 percent owner	600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Suzanne M Decker	director	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Bret Sanders	director	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
David M Orwasher	officer: President and COO	242 W 36TH ST, NEW YORK NY 10018